U.S. seeks to ‘onshore’ drug production in response to COVID-19. Is pharma even interested?

U.S. seeks to ‘onshore’ drug production in response to COVID-19. Is pharma even interested?

With the COVID-19 pandemic shining a spotlight on the global pharmaceutical supply chain, U.S. legislators have put forward a raft of legislation that would seek to “onshore” drug manufacturing at th…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *